Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosome changes in early bladder neoplasms.

A A Sandberg1

  • 1Southwest Biomedical Research Institute, Scottsdale, Arizona 85251.

Journal of Cellular Biochemistry. Supplement
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992
Same journal

Understanding immune cell trafficking patterns via in vivo bioluminescence imaging.

Journal of cellular biochemistry. Supplement·2003
Same journal

In vivo molecular imaging.

Journal of cellular biochemistry. Supplement·2003
Same journal

Introduction to the physics of molecular imaging with radioactive tracers in small animals.

Journal of cellular biochemistry. Supplement·2003
Same journal

Can small animal imaging accelerate drug development?

Journal of cellular biochemistry. Supplement·2003
Same journal

Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools.

Journal of cellular biochemistry. Supplement·2003
Same journal

Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.

Journal of cellular biochemistry. Supplement·2003
See all related articles

Detecting chromosomal changes like chromosome 9 loss in urine samples shows promise for early bladder cancer detection. Fluorescence in situ hybridization (FISH) can identify these genetic markers for bladder cancer diagnosis.

Area of Science:

  • Uro-oncology
  • Cytogenetics
  • Cancer Genomics

Background:

  • Limited cytogenetic studies exist for early bladder cancer due to technical challenges.
  • Extrapolation from advanced cancers suggests recurrent chromosomal anomalies in bladder tumorigenesis.
  • Specific chromosomal changes are not definitively established but recurrent anomalies are observed.

Purpose of the Study:

  • To explore the utility of cytogenetic anomalies in early bladder cancer detection.
  • To investigate the potential of fluorescence in situ hybridization (FISH) for identifying bladder cancer.
  • To correlate chromosomal changes with cancer stage and differentiation from benign conditions.

Main Methods:

  • Analysis of chromosomal anomalies in bladder cancer, including loss of chromosome 9 (-9) and trisomy 7 (+7).

Related Experiment Videos

  • Application of fluorescence in situ hybridization (FISH) for detecting specific chromosomal changes in urine samples.
  • Integration of cytogenetic data with molecular approaches like p53 mutation analysis.

    • Main Results:

    • Loss of chromosome 9 (-9) is a common early event in bladder cancer development.
    • Trisomy 7 (+7) is also a frequent anomaly, potentially useful for early detection.
    • Loss of the Y chromosome may correlate with advanced bladder cancer stages.

    Conclusions:

    • FISH analysis for chromosomes 7, 9, and Y offers a promising approach for early bladder cancer identification.
    • Combined cytogenetic and molecular studies can aid in differentiating early cancer from benign conditions and staging.
    • These findings provide valuable data for clinical and pathological assessment of bladder cancer.